MOLECULIN BIOTECH INC - COM (MBRX)

CUSIP: 60855D101

Q1 2017 13F Holders as of 31 Mar 2017

Share change
+699,779
SEC-reported price per share
$1.17
Number of holders
16
Value change
+$809,222
Number of buys
13
Number of sells
3

Security key

60855D101

Report period

Q1 2017

Institutions

16

Top holders

10

Ownership snapshot

Top reported holders of MBRX - MOLECULIN BIOTECH INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BANK OF AMERICA CORP /DE/
Disclosed value leader
BANK OF AMERICA CORP /DE/
Comparable rows
0/10
Latest evidence
31 Dec 2016
13F Highest disclosed value: $57,000 10 rows are not safely comparable across share classes. Showing 1-6 of 10 holder rows.

Quick read

BANK OF AMERICA CORP /DE/ has the largest disclosed position value at $57K.

0 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BANK OF AMERICA CORP /DE/'s linked filing trail.
Disclosed position value Top 5
BANK OF AMERICA CORP /DE/ $57K
TRUIST FINANCIAL CORP $46K
VANGUARD GROUP INC $41K
BlackRock Fund Advisors $41K
CITIGROUP INC $17K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 10 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BANK OF AMERICA CORP /DE/
13F
Company
13F
—
denominator unverified
$57,000
25,000 shares
— 31 Dec 2016
TRUIST FINANCIAL CORP
13F
Company
13F
—
denominator unverified
$46,000
20,000 shares
— 31 Dec 2016
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$41,000
17,958 shares
— 31 Dec 2016
BlackRock Fund Advisors
13F
Company
13F
—
denominator unverified
$41,000
17,868 shares
— 31 Dec 2016
CITIGROUP INC
13F
Company
13F
—
denominator unverified
$17,000
7,500 shares
— 31 Dec 2016
UBS Group AG
13F
Company
13F
—
denominator unverified
$5,000
2,122 shares
— 31 Dec 2016
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
16
Shares
784,355
Rows available
16
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2017 vs Q1 2017 Across Filers

Q1 2017 holders
16
Q1 2017 holders
16
Holder diff
0
Investor Q1 2017 Shares Q1 2017 Shares Share Diff Share Chg % Q1 2017 value Q1 2017 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .